FDA Brief

Warning letters Animal

FDA warning letter to

DeJong Family Dairy, LLC

MediumIssued Jul 30Posted Aug 18Center for Veterinary Medicine

FDA warned DeJong Family Dairy that it treated cows with an animal drug in ways the label and a veterinarian did not allow.

What happened

FDA inspected the Dorchester, Wisconsin dairy operation on April 6 and April 8, 2026, and issued a Form FDA 483 (a list of inspection observations) at the close of the inspection. The agency found that three cows were each given one syringe of an intramammary infusion (a drug put into the udder) once a day for several days, which did not match the manufacturer's labeled directions. The company responded on April 13, 2026, but FDA said the response lacked training records and treatment records showing correct drug use.

What FDA found

  1. The farm used the drug in a way that did not follow the approved label, which is called extralabel use.

    21 CFR 530.3(a)
  2. The extralabel use was not made by or on the lawful order of a licensed veterinarian with an existing veterinarian-client-patient relationship.

    21 CFR 530.11(a)
  3. Because the use did not meet these rules, the drug was considered unsafe and adulterated (adulterated means the product is legally unfit).

    Section 501(a)(5) of the FD&C Act [21 U.S.C. ยง 351(a)(5)]
  4. The company's April 13, 2026 response did not include documents showing employees were trained on proper drug use.

  5. The response did not include treatment records showing the drug and other drugs were used correctly.

What FDA wants

FDA asks the company to write back within 15 working days describing each corrective step taken, how it will prevent repeat violations, and copies of related records. If corrections cannot be finished in that time, the company must explain the delay and give a completion date.

Who should pay attention

  • dairy farms that use intramammary drugs on cows
  • veterinarians who write drug orders for dairy producers
  • dairy cooperatives and processors that buy milk from such farms

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Karcz Nation, LLC

    Wisconsin dairy farm sold cows for slaughter with illegal antibiotic residues after off-label ceftiofur and ampicillin use, FDA says.

    High risk
  2. John & Nicole Santos Dairy

    John & Nicole Santos Dairy of Hilmar, California sold dairy cows for slaughter containing ampicillin residues above the legal limit.

    High risk
  3. Wilson Livestock

    Wilson Livestock sold a heifer with excess desfuroylceftiofur residue and used a cephalosporin drug outside approved labeling for disease prevention.

    High risk
  4. Tex-Stein Dairy

    Tex-Stein Dairy sold a dairy cow for slaughter with illegal meloxicam and ceftiofur residues and kept incomplete treatment records.

    High risk